Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-03

Clinical Trial Update: Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients [Phase 1]

View source ↗

Summary

Phase 1 trial comparing standard versus high-dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia; results compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trivalent inactivated influenza vaccine (trivalent inactivated influenza vaccine)

Snippet

Sponsor: Vanderbilt University | Conditions: Pediatric Patients With Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2019-05-03